• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evaluating response to immunotherapy with F-FDG PET/CT: where do we stand?

作者信息

Aide Nicolas, De Pontdeville Michel, Lopci Egesta

机构信息

Nuclear Medicine Department, Centre Hospitalier Universitaire, Avenue Côte de Nacre, 14000, Caen, France.

Normandie University, Caen, France.

出版信息

Eur J Nucl Med Mol Imaging. 2020 May;47(5):1019-1021. doi: 10.1007/s00259-020-04702-4.

DOI:10.1007/s00259-020-04702-4
PMID:31996974
Abstract
摘要

相似文献

1
Evaluating response to immunotherapy with F-FDG PET/CT: where do we stand?用F-FDG PET/CT评估免疫治疗反应：我们目前的进展如何？
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1019-1021. doi: 10.1007/s00259-020-04702-4.
2
Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.基于双能计算机断层扫描的碘定量用于评估肺癌对放化疗/放疗的反应：与基于氟-18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的实体瘤正电子发射断层扫描/计算机断层扫描反应评估标准的比较
J Comput Assist Tomogr. 2018 Jul/Aug;42(4):614-622. doi: 10.1097/RCT.0000000000000734.
3
F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer.F-FDG PET/CT可预测肺癌免疫治疗所致甲状腺炎的发生。
J Nucl Med Technol. 2018 Sep;46(3):260-264. doi: 10.2967/jnmt.117.204933. Epub 2018 Mar 29.
4
[Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer].[18F-氟脱氧葡萄糖（FDG）正电子发射断层扫描-计算机断层扫描（PET-CT）在广泛期小细胞肺癌中的预后价值]
Zhonghua Zhong Liu Za Zhi. 2017 Nov 23;39(11):828-834. doi: 10.3760/cma.j.issn.0253-3766.2017.11.005.
5
[(18)F-fluorodeoxy glucose positron emission tomography/computed tomography manifestation and clinical characteristics of primary salivary gland-type lung cancer].[（18）F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在原发性涎腺型肺癌中的表现及临床特征]
Zhonghua Zhong Liu Za Zhi. 2019 Apr 23;41(4):288-293. doi: 10.3760/cma.j.issn.0253-3766.2019.04.008.
6
Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [F]-FDG PET/CT.[F]-FDG PET/CT检测到的正在接受抗PD-1免疫治疗的腹膜后纤维化。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1758-1759. doi: 10.1007/s00259-019-04352-1. Epub 2019 May 15.
7
F-FDG PET/CT in lung adenosquamous carcinoma and its correlation with clinicopathological features and prognosis.18F-FDG PET/CT 显像在肺鳞腺癌中的表现及其与临床病理特征和预后的关系。
Ann Nucl Med. 2020 May;34(5):314-321. doi: 10.1007/s12149-020-01450-1. Epub 2020 Feb 22.
8
Pulmonary mucosa-associated lymphoid tissue lymphoma: F-FDG PET/CT and CT findings in 28 patients.肺黏膜相关淋巴组织淋巴瘤：28例患者的F-FDG PET/CT及CT表现
Br J Radiol. 2017 Nov;90(1079):20170311. doi: 10.1259/bjr.20170311. Epub 2017 Oct 3.
9
18F-Deoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats.18F-脱氧葡萄糖（18F-FDG）正电子发射断层扫描/计算机断层扫描（PET/CT）监测大鼠 3 个不同部位 Walker-256 肿瘤模型的动态生长特征。
Med Sci Monit. 2019 Jan 19;25:558-564. doi: 10.12659/MSM.909286.
10
Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.氟代脱氧葡萄糖 F18 标记正电子发射断层扫描在高危肺结节诊断中的评估。
JAMA Surg. 2018 Apr 1;153(4):329-334. doi: 10.1001/jamasurg.2017.4495.

引用本文的文献

1
PET Imaging for Monitoring Cellular and Immunotherapy of Cancer.正电子发射断层扫描成像用于监测癌症的细胞和免疫治疗。
Cancer J. 2024;30(3):153-158. doi: 10.1097/PPO.0000000000000722.
2
Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas.影像引导下精准医学在嗜铬细胞瘤和副神经节瘤诊断与治疗中的应用
Cancers (Basel). 2023 Sep 21;15(18):4666. doi: 10.3390/cancers15184666.
3
Efficacy evaluation of neoadjuvant immunotherapy plus chemotherapy for non-small-cell lung cancer: comparison of PET/CT with postoperative pathology.

本文引用的文献

1
Hyperprogressive Disease in Patients with Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors: The Role of F-FDG PET/CT.接受检查点抑制剂治疗的非小细胞肺癌患者的超进展性疾病：F-FDG PET/CT 的作用。
J Nucl Med. 2020 Jun;61(6):821-826. doi: 10.2967/jnumed.119.237768. Epub 2019 Dec 20.
2
FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns.氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在非小细胞肺癌免疫治疗早期疗效评估中的应用：非典型演变模式的发生率及临床意义
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1158-1167. doi: 10.1007/s00259-019-04573-4. Epub 2019 Nov 23.
3
新辅助免疫联合化疗治疗非小细胞肺癌的疗效评价：PET/CT 与术后病理的比较。
Eur Radiol. 2023 Oct;33(10):6625-6635. doi: 10.1007/s00330-023-09922-4. Epub 2023 Jul 29.
4
Mannosylated-serum albumin nanoparticle imaging to monitor tumor-associated macrophages under anti-PD1 treatment.甘露糖化血清白蛋白纳米颗粒成像监测抗 PD1 治疗下的肿瘤相关巨噬细胞。
J Nanobiotechnology. 2023 Jan 27;21(1):31. doi: 10.1186/s12951-023-01791-9.
5
Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck Cancer.局部晚期头颈部鳞状细胞癌诱导化疗联合免疫治疗与单纯诱导化疗后早期代谢和形态学反应模式的差异与相似性。
Cancers (Basel). 2022 Sep 30;14(19):4811. doi: 10.3390/cancers14194811.
6
First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict Outcomes.非小细胞肺癌的一线帕博利珠单抗单药或联合治疗：基线代谢生物标志物可预测疗效。
Cancers (Basel). 2021 Dec 3;13(23):6096. doi: 10.3390/cancers13236096.
7
Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [F]FDG PET/CT in Metastatic Melanomas and Lung Cancer.基于[F]FDG PET/CT的免疫检查点抑制剂在转移性黑色素瘤和肺癌中的免疫治疗监测
J Clin Med. 2021 Nov 3;10(21):5160. doi: 10.3390/jcm10215160.
8
Immune Checkpoint Inhibitors in Advanced NSCLC: [F]FDG PET/CT as a Troubleshooter in Treatment Response.晚期非小细胞肺癌中的免疫检查点抑制剂：[F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描作为治疗反应的故障排除手段
Diagnostics (Basel). 2021 Sep 15;11(9):1681. doi: 10.3390/diagnostics11091681.
9
NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images.预测非小细胞肺癌对免疫检查点抑制剂（ICI）免疫治疗反应的生物标志物：从细胞到体内成像
Cancers (Basel). 2021 Sep 10;13(18):4543. doi: 10.3390/cancers13184543.
10
Assessment of early metabolic progression in melanoma patients under immunotherapy: an F-FDG PET/CT study.免疫治疗下黑色素瘤患者早期代谢进展的评估：一项F-FDG PET/CT研究。
EJNMMI Res. 2021 Sep 8;11(1):89. doi: 10.1186/s13550-021-00832-4.
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors.
氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG PET/CT）上的基线代谢肿瘤负荷可预测接受免疫检查点抑制剂治疗的晚期非小细胞肺癌（NSCLC）患者的预后。
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1147-1157. doi: 10.1007/s00259-019-04615-x. Epub 2019 Nov 21.
4
F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Assessing Tumor Response to Immunotherapy in Solid Tumors: Melanoma and Beyond.用于评估实体瘤免疫治疗肿瘤反应的F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描：黑色素瘤及其他。
PET Clin. 2020 Jan;15(1):11-22. doi: 10.1016/j.cpet.2019.08.007.
5
F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancer.氟代脱氧葡萄糖（18F-FDG）摄取在正电子发射断层扫描/计算机断层扫描（PET/CT）中是预测非小细胞肺癌对 PD-1 抗体治疗反应的潜在生物标志物。
Sci Rep. 2019 Sep 16;9(1):13362. doi: 10.1038/s41598-019-50079-2.
6
Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics.抗 PD-1 免疫治疗转移性黑色素瘤的预后和治疗 18F-FDG PET 生物标志物：与结局和转录组学的关联。
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2298-2310. doi: 10.1007/s00259-019-04411-7. Epub 2019 Jul 25.
7
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.CheckMate 141 随机 3 期临床试验的亚组分析：纳武利尤单抗治疗复发或转移性头颈部鳞状细胞癌，超出 RECIST 定义的进展
Cancer. 2019 Sep 15;125(18):3208-3218. doi: 10.1002/cncr.32190. Epub 2019 Jun 27.
8
Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression.纳武利尤单抗治疗晚期非小细胞肺癌患者进展后疗效和安全性的研究
Clin Lung Cancer. 2019 May;20(3):178-185.e2. doi: 10.1016/j.cllc.2019.02.001. Epub 2019 Feb 27.
9
Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST.使用氟代脱氧葡萄糖正电子发射断层扫描（FDG PET）监测非小细胞肺癌中基于抗程序性死亡蛋白1（anti-PD-1）的免疫治疗：iPERCIST的介绍
EJNMMI Res. 2019 Jan 29;9(1):8. doi: 10.1186/s13550-019-0473-1.
10
F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描用于监测转移性黑色素瘤患者的依匹单抗治疗。
J Nucl Med. 2019 Mar;60(3):335-341. doi: 10.2967/jnumed.118.213652. Epub 2018 Nov 9.